Doheny Asset Management /Ca Oncocyte Corp Transaction History

Doheny Asset Management /Ca

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$3.77 - $6.0 $218,283 - $347,400	-57,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $138,381 - $376,350	57,900 New	57,900 $301,000
Q4 2019 Feb 11, 2020	SELL	$1.51 - $2.27 $212,457 - $319,389	-140,700 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$1.59 - $2.51 $90,838 - $143,398	-57,131 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.49 - $5.45 $142,256 - $311,363	57,131 New	57,131 $142,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $275M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

Stay updated on Doheny Asset Management /Ca with notifications on news.